Great Valley Advisor Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,084
| Closed | -$618K | – | 1012 |
|
|
2025
Q4 | $618K | Hold |
6,084
| – | – | 0.01% | 576 |
|
|
2025
Q3 | $333K | Sell |
6,084
-20
| -0.3% | -$999 | 0.01% | 741 |
|
|
2025
Q2 | $325K | Sell |
6,104
-100
| -2% | -$5.08K | 0.01% | 723 |
|
|
2025
Q1 | $268K | Sell |
6,204
-1,023
| -14% | -$51.8K | 0.01% | 756 |
|
|
2024
Q4 | $406K | Sell |
7,227
-1,307
| -15% | -$81.3K | 0.01% | 618 |
|
|
2024
Q3 | $581K | Sell |
8,534
-157
| -2% | -$8.86K | 0.01% | 529 |
|
|
2024
Q2 | $367K | Buy |
8,691
+132
| +2% | +$7.26K | 0.01% | 604 |
|
|
2024
Q1 | $591K | Buy |
8,559
+1,475
| +21% | +$93.3K | 0.02% | 456 |
|
|
2023
Q4 | $524K | Buy |
7,084
+4
| +0.1% | +$262 | 0.02% | 447 |
|
|
2023
Q3 | $483K | Sell |
7,080
-1
| -0% | -$85 | 0.02% | 444 |
|
|
2023
Q2 | $665K | Sell |
7,081
-572
| -7% | -$44.6K | 0.03% | 386 |
|
|
2023
Q1 | $519K | Sell |
7,653
-250
| -3% | -$16.1K | 0.02% | 429 |
|
|
2022
Q4 | $391K | Sell |
7,903
-385
| -5% | -$15.7K | 0.02% | 488 |
|
|
2022
Q3 | $269K | Sell |
8,288
-1
| -0% | -$41 | 0.02% | 557 |
|
|
2022
Q2 | $327K | Sell |
8,289
-317
| -4% | -$17K | 0.02% | 528 |
|
|
2022
Q1 | $602K | Sell |
8,606
-573
| -6% | -$41.9K | 0.04% | 360 |
|
|
2021
Q4 | $714K | Sell |
9,179
-21,590
| -70% | -$1.91M | 0.04% | 318 |
|
|
2021
Q3 | $2.94M | Buy |
30,769
+8,200
| +36% | +$866K | 0.2% | 128 |
|
|
2021
Q2 | $2.81M | Buy |
22,569
+792
| +4% | +$94.5K | 0.21% | 127 |
|
|
2021
Q1 | $2.87M | Buy |
21,777
+1,837
| +9% | +$251K | 0.28% | 89 |
|
|
2020
Q4 | $2.64M | Sell |
19,940
-979
| -5% | -$118K | 0.27% | 86 |
|
|
2020
Q3 | $2.13M | Sell |
20,919
-2,301
| -10% | -$199K | 0.26% | 85 |
|
|
2020
Q2 | $2.02M | Sell |
23,220
-2,308
| -9% | -$184K | 0.33% | 82 |
|
|
2020
Q1 | $1.48M | Buy |
25,528
+3,217
| +14% | +$261K | 0.39% | 79 |
|
|
2019
Q4 | $2.06M | Buy |
22,311
+5,699
| +34% | +$501K | 0.46% | 69 |
|
|
2019
Q3 | $1.5M | Buy |
16,612
+4,554
| +38% | +$519K | 0.36% | 85 |
|
|
2019
Q2 | $1.42M | Buy |
12,058
+2,929
| +32% | +$295K | 0.36% | 89 |
|
|
2019
Q1 | $791K | Buy |
9,129
+4,203
| +85% | +$358K | 0.25% | 117 |
|
|
2018
Q4 | $311K | Buy |
+4,926
| New | +$338K | 0.12% | 158 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Great Valley Advisor Group's EXAS Position: Q1 2026 in Review
Great Valley Advisor Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,084 shares — an estimated $618K sold.
Great Valley Advisor Group first reported a position in EXAS in Q4 2018 and held it in 29 quarters. The position peaked at $2.94M in Q3 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Great Valley Advisor Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Great Valley Advisor Group sold 6,084 Exact Sciences shares in Q1 2026, an estimated $618K.
- Great Valley Advisor Group first reported a position in Exact Sciences in Q4 2018 and held it in 29 quarters.
- Great Valley Advisor Group's Exact Sciences position peaked at $2.94M in Q3 2021.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.